文献
J-GLOBAL ID:201702251035558402
整理番号:17A1549425
p.Ser549Arg(S549R)ゲート変異のイバカフトル-イスラエルの経験【Powered by NICT】
Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experience
著者 (16件):
Dagan Adi
(Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lili Safra Children’s Hospital, Chaim Sheba Medical Center at Tel Hashomer, Affiliated with Sackler Medical School, Tel Aviv University, Israel)
,
Cohen-Cymberknoh Malena
(Cystic Fibrosis Center, Hebrew University Hadassah Medical Center, Jerusalem, Israel)
,
Shteinberg Michal
(Cystic Fibrosis Center, Carmel Hospital, Ruth and Bruce Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel)
,
Levine Hagit
(Graub Cystic Fibrosis Center, Schneider Children’s Medical Center, Petach Tikva, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, Israel)
,
Vilozni Daphna
(Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lili Safra Children’s Hospital, Chaim Sheba Medical Center at Tel Hashomer, Affiliated with Sackler Medical School, Tel Aviv University, Israel)
,
Bezalel Yael
(Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lili Safra Children’s Hospital, Chaim Sheba Medical Center at Tel Hashomer, Affiliated with Sackler Medical School, Tel Aviv University, Israel)
,
Bar Aluma Bat-El
(Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lili Safra Children’s Hospital, Chaim Sheba Medical Center at Tel Hashomer, Affiliated with Sackler Medical School, Tel Aviv University, Israel)
,
Sarouk Ifat
(Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lili Safra Children’s Hospital, Chaim Sheba Medical Center at Tel Hashomer, Affiliated with Sackler Medical School, Tel Aviv University, Israel)
,
Ashkenazi Moshe
(Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lili Safra Children’s Hospital, Chaim Sheba Medical Center at Tel Hashomer, Affiliated with Sackler Medical School, Tel Aviv University, Israel)
,
Lavie Moran
(Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lili Safra Children’s Hospital, Chaim Sheba Medical Center at Tel Hashomer, Affiliated with Sackler Medical School, Tel Aviv University, Israel)
,
Tsabari Reuven
(Cystic Fibrosis Center, Hebrew University Hadassah Medical Center, Jerusalem, Israel)
,
Blau Hannah
(Graub Cystic Fibrosis Center, Schneider Children’s Medical Center, Petach Tikva, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, Israel)
,
Kerem Eitan
(Cystic Fibrosis Center, Hebrew University Hadassah Medical Center, Jerusalem, Israel)
,
Bentur Lea
(Cystic Fibrosis Center, Rambam Health Care Campus, Haifa, Israel)
,
Efrati Ori
(Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lili Safra Children’s Hospital, Chaim Sheba Medical Center at Tel Hashomer, Affiliated with Sackler Medical School, Tel Aviv University, Israel)
,
Livnat Galit
(Cystic Fibrosis Center, Carmel Hospital, Ruth and Bruce Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel)
資料名:
Respiratory Medicine
(Respiratory Medicine)
巻:
131
ページ:
225-228
発行年:
2017年
JST資料番号:
T0256A
ISSN:
0954-6111
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)